Impression Products v. Lexmark: One Authorized Sale Exhausts All Patent Rights

Impression Products, Inc. v. Lexmark International, Inc., 581 U.S. 360 (2017), is the Supreme Court’s definitive modern statement of the patent-exhaustion doctrine. Lexmark sold patented toner cartridges subject to a single-use, no-resale restriction, then sued to enforce that restriction as patent infringement when a remanufacturer refilled and resold the cartridges. Writing for the Court, Chief Justice Roberts held that an authorized sale exhausts all of a patentee’s patent rights in the item sold — no matter what post-sale restrictions the patentee purports to impose, and no matter whether the sale occurs in the United States or abroad. The decision swept away two Federal Circuit rules at once, confined post-sale restrictions to the domain of contract rather than patent, and grounded the whole doctrine in the common law’s ancient hostility to restraints on alienation.

At a glance

• Case: Impression Products, Inc. v. Lexmark International, Inc., 581 U.S. 360 (2017), Docket No. 15-1189
• Court: Supreme Court of the United States, on certiorari to the en banc Federal Circuit
• Decided: May 30, 2017
• Opinion: Chief Justice Roberts for the Court; Justice Ginsburg concurring in part and dissenting in part (as to international exhaustion); Justice Gorsuch took no part. The domestic holding was unanimous (8–0); the international holding was 7–1.
• Subject matter: Patented toner cartridges sold under post-sale single-use/no-resale restrictions, and cartridges first sold abroad
• Holding: A patentee’s authorized sale of a patented item exhausts all patent rights in that item, regardless of any post-sale restriction and regardless of where the sale occurred

The Return Program cartridges and the two questions

Lexmark makes and sells patented toner cartridges for its laser printers. Domestically it offered buyers a choice: a full-price “Regular Cartridge” with no strings attached, or a discounted “Return Program Cartridge” sold at roughly a twenty-percent reduction on the condition that the buyer use it only once and return the empty to Lexmark rather than reselling or refilling it. Lexmark also sold the same cartridges abroad. Impression Products acquired used Lexmark cartridges — both the restricted domestic ones and cartridges Lexmark had first sold overseas — refurbished them by defeating the microchip that enforced the single-use limit, refilled them with toner, and resold them in the United States in competition with Lexmark.

Lexmark sued Impression Products for patent infringement, presenting two distinct questions. First, a domestic question: could Lexmark sue for infringement over the Return Program cartridges, even though it had sold them, because the buyers had violated the single-use/no-resale restriction? Second, an international question: could Lexmark sue over the cartridges it had first sold abroad, on the theory that a foreign sale does not exhaust U.S. patent rights? The en banc Federal Circuit had answered yes to both — holding that a patentee may preserve its infringement remedy by imposing clear post-sale restrictions, and, following its own precedent in Jazz Photo Corp. v. International Trade Commission, that sales abroad never exhaust U.S. patent rights. The Supreme Court reversed on both.

Post-sale restrictions do not survive an authorized sale

On the domestic question the Court was categorical. “When a patentee sells one of its products,” Chief Justice Roberts explained, “the patentee can no longer control that item through the patent laws—its patent rights are said to ‘exhaust.’” The sale “terminates all patent rights to that item,” marking “the point where patent rights yield to the common law principle against restraints on alienation.” Because Lexmark had chosen to sell the Return Program cartridges, its patent rights in those cartridges were spent the moment ownership passed. The restriction did not preserve an infringement remedy.

The Court’s reasoning turned on the nature of the patent grant rather than on the clarity of the restriction. A patent gives its owner the right to exclude others from making, using, selling, or importing an invention; exhaustion recognizes that once the patentee has itself sold the article and collected its reward, the article “passe[s] outside of the patent monopoly.” At that point, Roberts wrote, “whatever rights Lexmark retained are a matter of the contracts with its purchasers, not the patent law.” A patentee “is free to set the price and negotiate contracts with purchasers, but may not, ‘by virtue of his patent,’ control the use or disposition’ of the product after ownership passes.” The single-use term might well bind Lexmark’s immediate buyers as a matter of contract; what it could not do was travel with the cartridge as a patent right enforceable against remanufacturers and other downstream possessors.

This is the doctrinally crucial move: the Court decoupled the enforceability of a restriction from the vehicle used to enforce it. Impression Products does not hold that Lexmark’s single-use condition is void or unlawful. It holds that the remedy for its breach lies in contract law, not in a patent infringement suit — and contract remedies run only against parties in privity, not against the world. By channeling post-sale control into contract, the Court preserved a patentee’s ability to bargain over price and terms while denying it the extraordinary leverage of patent’s exclusionary remedies over goods it has already sold.

Restraints on alienation and the borderless common law

Underlying both holdings is a principle far older than the Patent Act: the common law’s “refusal to permit restraints on the alienation of chattels.” Roberts drew on Lord Coke’s centuries-old rule that a condition forbidding the resale of a thing already sold is repugnant to the ownership transferred. Applied to patents, that principle explains why extending patent rights past the first sale is so disfavored. Allowing patentees to reach downstream would, the Court warned, “clog the channels of commerce, with little benefit from the extra control that the patentees retain.” In a modern economy where a single product may embody thousands of patents and pass through many hands, a rule permitting each patentee to attach enforceable use-and-resale conditions would make ordinary commerce a minefield of latent infringement liability.

That same common-law taproot drove the Court’s answer to the international question, where it parted ways with the Federal Circuit’s Jazz Photo rule. “An authorized sale outside the United States,” Roberts held, “just as one within the United States, exhausts all rights under the Patent Act.” Nothing in the text or history of the statute confined exhaustion to domestic sales. “Patent exhaustion, too, has its roots in the antipathy toward restraints on alienation,” the Court reasoned, “and nothing in the text or history of the Patent Act shows that Congress intended to confine that borderless common law principle to domestic sales.” The relevant act is the patentee’s own decision to relinquish the item in an authorized sale; where on the globe that sale happens does not change its exhausting effect.

The Court leaned heavily on its 2013 copyright decision in Kirtsaeng v. John Wiley & Sons, Inc., which had held that the copyright first-sale doctrine applies to copies lawfully made and sold abroad. Patent and copyright exhaustion share the same common-law pedigree, and the Court saw no reason to give the patent version a narrower geographic reach. Justice Ginsburg, who had dissented in Kirtsaeng, again dissented on this point, arguing that patent law is territorial and that a foreign sale — made under a foreign sovereign’s patent laws, or none at all — should not exhaust the distinct rights conferred by a United States patent. The majority disagreed: because U.S. law does not guarantee a patentee any particular reward on a foreign sale, the patentee’s decision to make that sale still triggers exhaustion of its U.S. rights.

Open questions

Impression Products settles the exhaustion trigger but leaves the contract frontier open. The Court was explicit that lawful post-sale restrictions may be “clear and enforceable” as contract terms, yet it said little about how far such terms reach, whether they survive against remote purchasers with notice, or how they interact with state-law limits on restraints and with antitrust and patent-misuse doctrines. The line between a “conditional sale” and a mere license — the latter still capable of limiting the authority of a sale and thus its exhausting effect — remains a live battleground; a genuine license that never transfers ownership can still cabin what downstream users are authorized to do. Patentees have since experimented with structuring transactions as licenses or leases rather than sales, and with contractual field-of-use and single-use terms enforced through supply-chain contracts, testing where authorized sale ends and mere authorization begins.

Implications

• Sell once, and the patent is spent. An authorized sale exhausts the patentee’s patent rights in that item; post-sale conduct by the buyer or by downstream possessors cannot be reached through an infringement suit, however explicit the restriction.
• Push restrictions into contract, not patent. Single-use, no-resale, and field-of-use conditions may be enforceable against your direct counterparty as contract terms — but they bind only parties in privity and carry contract remedies, not patent’s exclusionary muscle over the world.
• Global sales exhaust U.S. rights. After the overruling of Jazz Photo, a first sale abroad exhausts U.S. patent rights, so gray-market and reimportation strategies premised on territorial exhaustion no longer work; price discrimination across markets must be managed by contract and logistics, not by threat of U.S. infringement suits.
• Consider licensing instead of selling. Because exhaustion is triggered by a sale, some patentees restructure distribution as genuine licenses or leases that never transfer title — but courts scrutinize whether such arrangements are real licenses or disguised sales, and the substance controls.

Frequently asked questions

What is patent exhaustion? Patent exhaustion (the “first sale” doctrine) means that once a patentee makes an authorized sale of a patented item, it can no longer sue for patent infringement over how the buyer uses or resells that particular item. The patent rights in that item are “exhausted” by the sale.

Can a patentee enforce post-sale restrictions after Impression Products? Not through a patent infringement suit. The Court held that a lawful restriction — such as a single-use/no-resale condition — may be enforceable as a matter of contract law between the patentee and its buyer, but it cannot be enforced against downstream possessors as patent infringement because the authorized sale already exhausted the patent rights.

Do foreign sales exhaust U.S. patent rights? Yes. The Court held that an authorized sale abroad exhausts U.S. patent rights just as a domestic sale does, overruling the Federal Circuit’s contrary rule in Jazz Photo and aligning patent law with the copyright reasoning of Kirtsaeng v. John Wiley & Sons.

Authorities and sources

• Impression Products, Inc. v. Lexmark International, Inc., 581 U.S. 360 (2017), Docket No. 15-1189 (decided May 30, 2017). Official slip opinion (Supreme Court); Justia; Cornell Legal Information Institute.
• Oral argument, vote breakdown, and case summary via Oyez and SCOTUSblog case page.
• Roberts authorship, the 8–0 domestic / 7–1 international split, Ginsburg’s partial dissent, Gorsuch taking no part, the overruling of Jazz Photo, and the Kirtsaeng analogy corroborated by Wikipedia: Impression Products, Inc. v. Lexmark International, Inc..